Growing Hospital Acquired Infections (HAIs) or nosocomial infections are expected to drive the antibacterial glass market in the coming years. Traditional techniques of decontamination such as washing hands at periodic intervals are insufficient in a healthcare setting. Antibacterial glass provides an effective solution against bacteria such as MRSA (Methicillin-Resistant Staphylococcus Aureus), which is resistant to certain antibiotics. In addition, the market for antimicrobial coatings on medical devices is expected to witness growth over the forecast period, thus propelling the demand for antibacterial glass. However, consumer awareness regarding the role of antibacterial glass in minimizing infections is low, especially in developing nations. Users are price sensitive and the added cost of antibacterial glass as compared to its traditional alternative is among the key factors restraining industry growth.
Europe is expected to remain the market leader over the forecast period due to high degree of acceptance of antibacterial glass coupled with the presence of key players such as AGC Glass Europe in the region. The European market is expected to grow at a CAGR of 7.0% from 2012 to 2018, significantly higher than the global average of 6.3%. In terms of application, hospitals held the highest market share, and were valued at USD 53.3 million in 2012. Household and other applications are expected to witness slow growth in the coming years.
Silver was the largest market in terms of active ingredients. AGC Glass Europe uses silver to infuse glass and make it antibacterial nature, while other companies use silver and other ingredients such as zinc and copper for coating the glass.
The market is highly consolidated, with companies such as AGC Glass Europe and Nippon Sheet Glass involved in manufacturing of antibacterial glass through infusion and coating respectively. Majority of industry participants have distribution networks and are not involved in the production process.
